Prognostic Models for S-Phase Fraction in Soft Tissue Sarcoma
Author Information
Author(s): Gustafson P, Baldetorp B, Fernö M, Åkerman M
Primary Institution: Department of Orthopedics, University Hospital, Lund, Sweden
Hypothesis
Can alternative models for calculating S-phase fraction reduce the failure rate while retaining prognostic value?
Conclusion
The Baisch method for calculating S-phase fraction is preferable for identifying low-risk and high-risk patients in soft tissue sarcoma.
Supporting Evidence
- The 5-year metastasis-free survival rate was significantly higher in the low-risk group defined by the Baisch method.
- Using MultiCycle software, the 5-year metastasis-free survival rate varied based on background correction methods.
Takeaway
Doctors can use a special test to see how likely it is for patients with a certain type of cancer to get worse, and one way of doing this works better than others.
Methodology
S-phase fraction was calculated using the Baisch method and MultiCycle software on flow cytometric DNA histograms.
Limitations
The Baisch method has a high failure rate of around 40%.
Participant Demographics
Patients with soft tissue sarcoma of the locomotor system.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website